You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟民製藥(603222.SH):2020年度淨利預降85.55%-100%
格隆匯 01-29 19:02

格隆匯1月29日丨濟民製藥(603222.SH)發佈2020年年度業績預吿,預計2020年年度實現歸屬於上市公司股東的淨利潤較上年同期減少5919.87萬元-6919.87萬元,同比下降85.55%-100%。

預計2020年年度歸屬於上市公司股東的扣除非經常性損益的淨利潤較上年同期增加2094.57-3094.57萬元,歸屬於上市公司股東的扣除非經常性損益的淨利潤由虧損轉為盈利。

2020年,公司淨利潤較上年同期呈現較大幅度下滑,主要是子公司鄂州二醫院計提訴訟損失、鄆城新友誼醫院商譽減值及公允價值變動損失、應收趙選民股權回購款計提信用損失所致。主營業務方面,受疫情影響,公司大輸液和醫療服務業務收入較上年同期均呈現一定程度的下滑,但醫療器械業務收入實現較大幅度增長,帶動公司整體主營業務收入實現增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account